Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2

Journal of Clinical Investigation

Volumn 98, Issue 9, 1996, Pages 2076-2085

  Reuter, Brian K ^a   Asfaha, Samuel ^a   Buret, André ^a   Sharkey, Keith A ^a   Wallace, John L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

inflammatory bowel disease; mucosal defense; nonsteroidal antiinflammatory drug; prostaglandins; ulcer

Indexed keywords

6 (2,4 DIFLUOROPHENYLTHIO) 5 METHANESULFONAMIDO 1 INDANONE; ACETYLSALICYLIC ACID; DICLOFENAC; ETODOLAC; MESSENGER RNA; MYELOPEROXIDASE; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON INJURY; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; MALE; MORTALITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM;

EID: 0029907525     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119013     Document Type: Article

References (48)

1. Soll, A.H., W.M. Weinstein, J. Kurata, and D, McCarthy. 1991. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann. Intern. Med. 114: 307-319.
2. Xie, W., D.L. Robertson, and D.L. Simmons. 1992. Mitogen-inducible prostaglandin G/H synthase: a new target for nonsteroidal antiinflammatory drugs. Drug Dev. Res. 25:249-265.
3. Meade, E.A., W.L. Smith, and D.L. DeWitt. 1993. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 268:6610-6614.
4. Mitchell, J.A., P. Akarasereenont, C. Thiemermann, R.J. Flower, and J.R. Vane. 1993. Selectivity of nonsteroidal antiinflammalory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. USA. 90:11693-11697.
5. Vane, J.R., J.A. Mitchell, I. Appleton, A. Tomlinson, D. Bishop-Bailey, J. Croxtall, and D.A. Willoughby. 1994. Inducible isoforms of cyclooxygenase and nitric oxide synthase in inflammation. Proc. Natl. Acad. Sci. USA. 91:2046-2050.
6. Masferrer, J.L., B.S. Zweifel, P.T. Manning, S.D. Hauser, K.M. Leahy, W.G. Smith, P.C. Isakson, and K. Seibert. 1994. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. USA. 91:3228-3232.
7. Chan, C.C., S. Boyce, C. Brideau, A.W. Ford-Hutchinson, R. Gordon, D. Guay, R.G. Hill, C.S. Li, J. Mancini, M. Penneton et al. 1995. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal antiinflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J. Pharmacol. Exp. Ther. 274:1531-1537.
8. Seibert, K., Y. Zhang, K. Leahy, S. Hauser, J. Masferrer, W. Perkins, L. Lee, and P. Isakson. 1994. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. USA. 91:12013-12017.
9. Schattenkirchner, M. 1990. An updated safety profile of etodolac in several thousand patients. Eur. J. Rheumatol. Inflammation. 10:56-65.
10. Willkens, R.F. 1990. An overview of the long-term safety experience of nabumetone. Drugs. 40 (Suppl. 5):34-37.
11. Glaser, K., M.L. Seng, K. OíNeill, M. Belfast, D. Hartman, R. Carlson, A. Kreft, D. Kubrak, C.L. Hsiao, and B. Weichman. 1995. Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1. Eur. J. Pharmacol. 281:107-111.
12. Stadler, P., D. Armstrong, D. Margalith, E. Saraga, M. Stolte, P. Lualdi, G. Mautone, and A. Louis. 1991. Diclofenac delays healing of gastroduodenal mucosal lesions. Double-blind, placebo-controlled endoscopie study in healthy volunteers. Dig. Dis. Sci. 36:594-600.
13. Kaufmann, H.J., and H.L. Taubin. 1987. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann. Intern. Med. 107:513-516.
14. 4 synthesis. Gastroenterology. 102:18-27.
15. Morris, G.P., P.L. Beck, M.S. Herridge, W.T. Depew, M.R. Szewczyk, and J.L. Wallace. 1989. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 96:795-803.
16. Melarange, R., C. Gentry, M. Durie, C. O'Connell, and P.R. Blower. 1994. Gastrointestinal irritancy, antiinflammatory activity, and prostanoid inhibition in the rat: differentiation of effects between nabumetone and etodolac. Dig. Dis. Sci. 39:601-608.
17. Wallace, J.L., B. Reuter, C. Cicala, W. McKnight, M. Grisham, and G. Cirino. 1994. A diclofenac derivative without ulcerogenic properties. Eur. J. Pharmacol. 257:249-255.
18. Reuter, B.K., G. Cirino, and J.L. Wallace. 1994. Markedly reduced intestinal toxicity of a diclofenac derivative. Life Sci. 55:PL1-PL8.
19. Elliott, S.N., W. McKnight, G. Cirino, and J.L. Wallace. 1995. A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology. 109:524-530.
20. Wallace, J.L., and C.M. Keenan. 1990. An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. Am. J. Physiol. 258:G527-G534.
21. Wallace, J.L., W. McKnight, P. Del Soldato, A.R. Baydoun, G. Cirino. 1995. Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative. J. Clin. Invest. 96:2711-2718.
22. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
23. Wong, H., W.D. Anderson, T. Cheng, and K.T. Riabowol. 1994. Monitoring mRNA expression by polymerase chain reaction: the 'primer-dropping" method. Anal. Biochem 223:251-258.
24. Feng, L., W. Sun, Y. Xia, W.W. Tang, P. Chanmugam, E. Soyoola, C.B. Wilson, and D. Hwang. 1993. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch. Biochem. Biophys. 307:361-368.
25. Kennedy, B.P., C.C. Chan, S.A. Culp, and W.A. Cromlish. 1993. Cloning and expression of rat prostaglandin endoperoxide synthase (cyclooxygenase)-2 cDNA. Biochem. Biophys. Res. Commun. 197:494-500.
26. O'Banion, M.K., V.D. Winn, and D.A. Young. 1992. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc. Natl. Acad. Sci. USA. 89:4888-4892.
27. Kargman, S.L., G.P. O'Neill, P.J. Vickers, J.F. Evans, J.A. Mancini, and S. Jothy. 1995. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res. 55:2556-2559.
28. Flower, R.J., and J.R. Vane. 1972. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidephenol). Nature (Lond.). 120:412-411.
29. Xie, W., J.G. Chipman, D.L. Robertson, R.L. Erikson, and D.L. Simmons. 1991. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. 88:2692-2696.
30. Wu, K.K., R. Sanduja, T. Ah-Lim, B. Ferhanoglu, and D.S. Loose-Mitchell. 1991. Aspirin inhibits interleukin 1-induced prostaglandin H synthase expression in cultured endothelial cells. Proc. Natl. Acad. Sci. USA. 88:2384-2387.
31. Adams, J., Y. Collaco-Moraes, and J. De Belleroche. 1996. Cyclooxygenase-2 induction in cerebral cortex: an intracellular response to synaptic excitation. J. Neurochem. 66:6-13.
32. Shoda, T., K. Hatanaka, M. Saito, M. Majima, M. Ogino, Y. Harada, M. Nishijima, M. Katori, and S. Yamamoto. 1995. Induction of cyclooxygenase type-2 (COX-2) in rat endometrium at the peak of serum estradiol during the estrus cycle. Jpn. J. Pharmacol. 69:289-291.
33. Slater, D.M., L.C. Berger, R. Newton, G.E. Moore, and P.R. Bennett. 1995. Expression of cyclooxygenase types 1 and 2 in human fetal membranes at term. Am. J. Obstet. Gynecol. 172:77-82.
34. DuBois, R.N., A. Radhika, B.S. Reddy, and A.J. Entingh. 1996. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology. 110:1259-1262.
35. Gustafson-Svärd, C., I. Lilja, O. Hallböök, and R. Sjödahl. 1996. Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats. Gut. 38: 79-84.
36. Eberhart, C.E., R.J. Coffey, A. Radhika, F.M. Giardiello, S. Ferrenbach, and R.N. DuBois. 1994. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenlerology. 107:1183-1188.
37. Sano, H., Y. Kawahto, R.L. Wilder, A. Hashiramot, S. Mukai, K. Asai, S. Kimura, H. Kato, M. Kondo, and T. Hla. 1995. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55:3785-3789.
38. Chang, A.D., K.S. Ramanujam, and K.T. Wilson. 1996. Co-expression of inducible nitric oxide synthase (iNOS), cyclooxygenase (COX-2), and TGF-β in rat models of colitis. Gastroenterology. 110:A881. (Abstr.)
39. Tessner, T., S.M. Cohn, and W.F. Stenson. Prostaglandins enhance epithelial regeneration in dextran sodium sulfate induced colitis. Gastroenterology. 110:A1027. (Abstr.)
40. Fu, S., K.S. Ramanujam, S.J. Meltzer, and K.T. Wilson. 1996. Inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX-2) expression in ulcerative colitis and Crohn's disease. Gastroenterology. 110:A910. (Abstr.)
41. 2 before and after induction of colitis with trinitrobenzenesulfonic acid in rats decreases inflammation. Gastroenterology. 96: 1290-1300.
42. Fedorak, R.N., L.R. Empey, C. MacArthur, and L.D. Jewell. 1990. Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats. Gastroenterology. 98:615-625.
43. Wong, K., and F. Freund. 1981. Inhibition of n-formylmethionyl-leucylphenylalanine induced respiratory burst in human neutrophils by adrenergic agonists and prostaglandins of the E series. Can. J. Physiol. Pharmacol. 59:915-920.
44. 4 release from activated neutrophils. Proc. Natl. Acad. Sci. USA. 80:4349-4353.
45. 2. Biochem. Biophys. Res. Commun. 137:404-410.
46. Murch, S.H., V.A. Lamkin, M.O. Savage, J.A. Walker-Smith, and T.T. MacDonald. 1991. Serum concentrations of tumour necrosis factor α in childhood chronic inflammatory bowel disease. Gut. 32:913-917.
47. Van Dullemen, H.M., S.J.H. Van Deventer, D.W. Hommes, H.A. Bijl, J. Jansen, G.N.J. Tytgat, and J. Woody. 1995. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology. 109:129-135.
48. Asako, H., P. Kubes, J.L. Wallace, R.E. Wolf, and D.N. Granger. 1992. Modulation of leukocyte adhesion in rat mesenteric venules by aspirin and salicylate. Gastroenterology. 103:146-152.